1. Inicio
  2. Proyectos y Estudios
  3. Optimization of Diagnosis, Measurable Residual Disease Assessment, and Study of the Immunological Microenvironment: Towards Personalized Therapy in Acute Lymphoblastic Leukemia

Optimization of Diagnosis, Measurable Residual Disease Assessment, and Study of the Immunological Microenvironment: Towards Personalized Therapy in Acute Lymphoblastic Leukemia

Datos básicos

RRHH NACIONAL Finan. Competitiva Privada 100.600,00 € PRDVA246268GIL Año de incio: 2024 Año de finalización: 2028

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

FUNDACIÓN CIENTÍFICA AECC

Resultados del Ensayo Clínico

Atypical B-Cell Acute Lymphoblastic Leukemia with iAMP21 in the Context of Constitutional Ring Chromosome 21: A Case Report and Review of the Genetic Insights

Gil, JV; (...); Llop, M

Article. 10.3390/ijms26010357. 2025


Cita

Compartir